USMLE Step 3 study materials
USMLE Step 3 study resources

A Critical Value at 23:40 on a Cross-Cover List

USMLE Step 3 · Put your knowledge to work in context.

All case studies

A Critical Value at 23:40 on a Cross-Cover List

You are the night-float resident covering six inpatient units at a community hospital; your cross-cover list has 62 patients and none of them are yours. At 23:40 the laboratory calls a critical potassium of 6.8 mmol/L, confirmed on repeat, for a 58-year-old man admitted three days ago with cellulitis. He is not on your service; his primary team signed out at 19:00. Chart review shows an eGFR of 28 mL/min/1.73 m², lisinopril taken for two years, and trimethoprim-sulfamethoxazole started with this admission. Last vitals at 21:00: heart rate 88, blood pressure 138/76, respiratory rate 16, oxygen saturation 96%. The result auto-released to the patient portal 15 minutes ago, and the patient has messaged the team asking, "is this bad?"

1. What do you do in the next 30 minutes, and why is this patient at particularly high risk?

Read the worked answer

Treat the patient before you finish the chart. Potassium 6.8 with an eGFR of 28 is an emergency regardless of whose patient he is.

First 30 minutes:

  1. Get an ECG. Peaked T waves, QRS widening, or a sine wave → IV calcium immediately and call critical care.
  2. Continuous cardiac monitoring; assess for weakness, palpitations, and volume status.
  3. Stop the offending drugs now: lisinopril and trimethoprim-sulfamethoxazole, plus any potassium supplements or salt substitutes.
  4. Treat: calcium for ECG changes; insulin with dextrose ± nebulized albuterol to shift; then removal with a potassium binder, loop diuretic if he is making urine, or dialysis if refractory.
  5. Recheck potassium in 1–2 hours and repeat the ECG.

Why he is high risk - the "triple whammy": chronic kidney disease (eGFR 28) plus an ACE inhibitor plus trimethoprim, which blocks distal tubular sodium channels in an amiloride-like fashion and impairs potassium excretion. Add the acute kidney injury of sepsis/cellulitis and you have a predictable, pharmacy-visible interaction. Order the ECG and the calcium while you are still on the phone with the lab.

2. Describe the communication loop you would run - who you call, in what order, and what you document. Include how you handle the portal message.

Read the worked answer

Closed loop means the message returns to the sender.

Sequence:

  1. Bedside nurse first - they can act while you travel.
  2. Evaluate the patient yourself; do not delegate the assessment.
  3. Call the covering attending for the primary service. If unreachable within a defined window (e.g., 10–15 minutes), escalate to the rapid response team or the in-house attending. A critical value does not wait for a call-back - "not my patient" is not a clinical category at 23:40.
  4. Read-back: confirm the covering clinician repeats back the potassium, your interventions, and the recheck plan.

Document: time the result was received, time of your bedside assessment, orders placed, time the covering team was reached and by whom, and the read-back.

Portal message: the result is already visible and he has asked a direct question. Answer it today, in plain language - "your potassium is high; we are treating it now and will recheck it within the hour" - and route it to the primary team's inbox. An unanswered portal message attached to an unmanaged critical value is its own safety event.

Sign-out: hand off explicitly with pending labs and a contingency plan ("if K >6.0 on recheck, call ICU").

3. The patient stabilizes. In the safety huddle the next morning, what process changes would you propose, and how would you frame the individual versus system accountability?

Read the worked answer

Blame the process, not the night-float.

Order-entry fixes:

  • A best-practice advisory or hard stop for trimethoprim-sulfamethoxazole + ACE inhibitor/ARB in CKD, with renal dosing alerts.
  • Default order sets for cellulitis that surface renal-adjusted alternatives, and a potassium check before and after starting an ACE inhibitor or MRA in CKD.

Result-routing fix: auto-release of critical results to patient portals should trigger a parallel alert to the covering clinician - this is a health-IT problem, not a diligence problem.

Review: file a safety-event report and take it to M&M; interview the night team about the 23:40 handoff and whether the covering structure was adequate.

Disclosure: tell the patient what happened and what changed - open disclosure is both ethical and expected.

Metrics to re-audit in 3 months: time from critical result to clinical action, percentage of critical values with documented read-back, and the rate of high-risk potassium-raising combinations ordered in CKD.

Framing: the individual lesson is "cross-cover must treat"; the system lesson is "never make the drug combination orderable without a warning." Only the second one prevents the next case.